SBIR Phase I: Microbial Fermentation Bioprocess to Produce and Extract Platform Chemicals from the Dairy Industry Acid Whey Waste Stream.
SBIR 第一阶段:微生物发酵生物过程,从乳制品工业酸性乳清废物流中生产和提取平台化学品。
基本信息
- 批准号:1820211
- 负责人:
- 金额:$ 22.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-15 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the commercialization of a fermentation bioprocess that can bring significant benefits for the dairy industry - called the WheyAway system. By initially addressing the problem of handling acid whey, a waste stream generated by all Greek yogurt and cottage cheese producers - the WheyAway can convert the cost of waste handling into a revenue by producing valuable bio-oil platform chemicals. The WheyAway can economically convert the acid whey waste stream to bio-oil on-site, allowing our customers to effectively install biorefineries at each of their plants. In comparison to anaerobic digestion, the WheyAway system can provide several multiples greater economic value. These bio-oils can be used as biofuel feedstocks, animal feed additives, and specialty chemicals. Converting acid whey yields a significant market opportunity with projected impact that could simultaneously offset ~435,000 gallons of diesel used to truck this waste off-site and eliminate ~18,000 tons of greenhouse gases from being emitted to the atmosphere. In the future, this bioprocess can be tuned to address other dairy processing streams, allowing the WheyAway to provide value to stakeholders across the entire dairy production value chain.This SBIR Phase I project proposes to scale-up and optimize a novel fermentation bioprocess called the WheyAway system, and can economically convert acid whey waste into valuable platform chemicals, to provide value to Greek yogurt and cottage cheese producers. Plan is to scale to maximize bio-oil production and conversion efficiency through system optimization. A key focus will be to lower the capital cost for the extraction process. Through the tasks proposed for this SBIR, objectives to scale to a 5x larger reactor, lower operating expense by 20%, and lower the capital cost of the currently expensive bio-oil extraction process by 10x. Additionally, potential to convert other dairy process streams, such as sweet whey, will be evaluated, which could unlock larger opportunities in the dairy production value chain.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
这个小企业创新研究(SBIR)项目的更广泛的影响/商业潜力是发酵生物过程的商业化,可以为乳制品行业带来显着的利益-称为WheyAway系统。通过最初解决处理酸乳清的问题,所有希腊酸奶和农家奶酪生产商产生的废物流-WhyAway可以通过生产有价值的生物油平台化学品将废物处理的成本转化为收入。WheyAway可以经济地将酸乳清废物流现场转化为生物油,使我们的客户能够有效地在每个工厂安装生物炼油厂。与厌氧消化相比,WheyAway系统可以提供数倍的经济价值。这些生物油可用作生物燃料原料、动物饲料添加剂和特种化学品。转化酸乳清产生了一个重要的市场机会,预计影响可以同时抵消用于将这种废物运至场外的约435,000加仑柴油,并消除约18,000吨温室气体排放到大气中。在未来,这一生物工艺可以调整到其他乳制品加工流程,使WheyAway为整个乳制品生产价值链的利益相关者提供价值。SBIR第一阶段项目提出扩大和优化一种称为WheyAway系统的新型发酵生物工艺,并可以经济地将酸乳清废物转化为有价值的平台化学品,为希腊酸奶和白干酪生产商提供价值。计划通过系统优化扩大规模,以最大限度地提高生物油产量和转化效率。一个关键的重点将是降低提取过程的资本成本。通过为该SBIR提出的任务,目标是扩大到5倍大的反应器,将运营费用降低20%,并将目前昂贵的生物油提取工艺的资本成本降低10倍。此外,还将评估转换其他乳制品加工流程(如甜乳清)的潜力,这可能会在乳制品生产价值链中释放更大的机会。该奖项反映了NSF的法定使命,并被认为值得通过使用基金会的知识价值和更广泛的影响审查标准进行评估来支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Juan Guzman其他文献
The insect microbiome is a vast source of bioactive small molecules
昆虫微生物组是生物活性小分子的一个巨大来源
- DOI:
10.1039/d3np00054k - 发表时间:
2024-06-19 - 期刊:
- 影响因子:10.600
- 作者:
Carlismari Oliveira Grundmann;Juan Guzman;Andreas Vilcinskas;Mônica Tallarico Pupo - 通讯作者:
Mônica Tallarico Pupo
MP63-19 THE VALUE OF URODYNAMICS PRIOR TO SACRAL NEUROMODULATION IN MEN
- DOI:
10.1016/j.juro.2017.02.1971 - 发表时间:
2017-04-01 - 期刊:
- 影响因子:
- 作者:
Elodi Dielubanza;Bradley Gill;Shree Agrawal;Henry Okafor;Jessica Lloyd;Juan Guzman;Courtenay Moore;Howard B. Goldman;Sandip Vasavada;Raymond Rackley - 通讯作者:
Raymond Rackley
The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer
微小 RNA miR-454 和中介复合物成分 MED12 是前列腺癌中雄激素受体通路的调节因子
- DOI:
10.1038/s41598-025-95250-0 - 发表时间:
2025-03-25 - 期刊:
- 影响因子:3.900
- 作者:
Juan Guzman;Martin Hart;Katrin Weigelt;Angela Neumann;Achim Aigner;Chiara Andolfi;Florian Handle;Stefanie Rheinheimer;Ulrike Fischer;Uta D. Immel;Verena Lieb;Eckart Meese;Zoran Culig;Bernd Wullich;Helge Taubert;Sven Wach - 通讯作者:
Sven Wach
Training of Traffic Incident Responders
交通事故响应人员培训
- DOI:
10.17226/22810 - 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Nick Owens;Juan Guzman;Kevin M. Ford;J. Fields;April Armstrong;Kari Beasley;Christopher Armstrong;C. Mitchell;Lisa Bedsole;R. Brewster;K. McGinnis;Ron Moore;C. Gallagher;Gary Williams;J. Connor - 通讯作者:
J. Connor
MP87-03 DOUBLE-LAYER VESICOURETHRAL ANASTOMOSIS ASSOCIATED WITH IMPROVED EARLY CONTINENCE AFTER ROBOTIC RADICAL PROSTATECTOMY
- DOI:
10.1016/j.juro.2016.02.2353 - 发表时间:
2016-04-01 - 期刊:
- 影响因子:
- 作者:
Juan Guzman;Ricardo Sanchez-Ortiz - 通讯作者:
Ricardo Sanchez-Ortiz
Juan Guzman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Juan Guzman', 18)}}的其他基金
SBIR Phase II: Microbial Fermentation Bioprocess to Produce and Extract Platform Chemicals from the Dairy Industry Acid Whey Waste Stream.
SBIR 第二阶段:微生物发酵生物过程,从乳制品工业酸性乳清废物流中生产和提取平台化学品。
- 批准号:
1951231 - 财政年份:2020
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
相似国自然基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark
Supercooled Phase Transition
- 批准号:24ZR1429700
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
ATLAS实验探测器Phase 2升级
- 批准号:11961141014
- 批准年份:2019
- 资助金额:3350 万元
- 项目类别:国际(地区)合作与交流项目
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
- 批准号:41802035
- 批准年份:2018
- 资助金额:12.0 万元
- 项目类别:青年科学基金项目
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究
- 批准号:61675216
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Phase-type分布的多状态系统可靠性模型研究
- 批准号:71501183
- 批准年份:2015
- 资助金额:17.4 万元
- 项目类别:青年科学基金项目
纳米(I-Phase+α-Mg)准共晶的临界半固态形成条件及生长机制
- 批准号:51201142
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
连续Phase-Type分布数据拟合方法及其应用研究
- 批准号:11101428
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
D-Phase准晶体的电子行为各向异性的研究
- 批准号:19374069
- 批准年份:1993
- 资助金额:6.4 万元
- 项目类别:面上项目
相似海外基金
SBIR Phase I: Boosting Industrial Bio-Fermentation with Microbial Stem Cells
SBIR 第一阶段:利用微生物干细胞促进工业生物发酵
- 批准号:
2222602 - 财政年份:2023
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase II: Microbial Discovery and Biosynthesis of Targeted Protease Inhibitors (COVID-19)
SBIR 第二阶段:微生物发现和靶向蛋白酶抑制剂(COVID-19)的生物合成
- 批准号:
2213051 - 财政年份:2022
- 资助金额:
$ 22.49万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Microbial production of paraxanthine, a caffeine replacement
SBIR 第一阶段:微生物生产副黄嘌呤(一种咖啡因替代品)
- 批准号:
2039060 - 财政年份:2021
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase I: Determine Performance Characteristics During Cultivation of Living Organisms in a Novel Single-Use Horizontal Modular and Pressurizable Microbial Fermentor
SBIR 第一阶段:确定新型一次性卧式模块化加压微生物发酵罐中活体培养过程中的性能特征
- 批准号:
2036270 - 财政年份:2021
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase II: Bacteriophage-Based Microbial Gene Therapy Platform for In Situ Engineering of Microbiomes
SBIR II 期:基于噬菌体的微生物基因治疗平台,用于微生物组的原位工程
- 批准号:
2126838 - 财政年份:2021
- 资助金额:
$ 22.49万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Novel Test Kit for Detection of Microbial Corrosion in Petroleum Systems
SBIR 第一阶段:用于检测石油系统中微生物腐蚀的新型测试套件
- 批准号:
2112183 - 财政年份:2021
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase I: Mining microbial diversity to culture new categories of cheese and other sustainable foods
SBIR 第一阶段:挖掘微生物多样性以培养新类别的奶酪和其他可持续食品
- 批准号:
2112405 - 财政年份:2021
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase I: Aerogels Derived from Genetically Engineered Microbial Cells
SBIR 第一阶段:源自基因工程微生物细胞的气凝胶
- 批准号:
2050101 - 财政年份:2021
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase II: Harnessing Untapped Food-borne Microbial Diversity to Rationally Engineer Novel Healthy Foods
SBIR 第二阶段:利用未开发的食源性微生物多样性来合理设计新型健康食品
- 批准号:
2054208 - 财政年份:2021
- 资助金额:
$ 22.49万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Bacteriophage-Based Microbial Gene Therapy Platform for In Situ Engineering of Microbiomes
SBIR 第一阶段:基于噬菌体的微生物基因治疗平台,用于微生物组的原位工程
- 批准号:
2014888 - 财政年份:2020
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant














{{item.name}}会员




